Article Text

Download PDFPDF

Letter
Authors’ response: surgery rates in IBD
  1. Christine Rungoe,
  2. Tine Jess
  1. Department of Epidemiology Research, Statens Serum Institut, Copenhagen S, Denmark
  1. Correspondence to Dr Tine Jess, Department of Epidemiology Research, Statens Serum Institut, Artillerivej 5, DK-2300 Copenhagen S, Denmark; tjs{at}ssi.dk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

To the Editor,

We thank Dr Tøttrup and colleagues for their comments1 on our recent paper on decreasing risk of surgery over time among Danish patients with IBD.2 We agree with the authors that it is not certain the observed decrease in surgery is explained by the parallel changes in medication use. However, results do not reflect the fact that outpatients were included in later cohorts. This was tested thoroughly and—as described in the paper—restricting analyses to inpatients only, we obtained nearly identical results. In other words, even among inpatients, a statistically significant decrease in surgery over time was observed.

References

Footnotes

  • Correction notice The title of this letter has changed since published Online First.

  • Contributors Both authors contributed equally in this manuscript.

  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles

  • PostScript
    Anders Tøttrup Bente Mertz Nørgård Niels Qvist